PI
ALNY icon

PEAK6 Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

PEAK6 Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.17M Buy
29,700
+21,300
+254% +$5.55M 0.02% 665
2024
Q2 		$2.04M Buy
8,400
+5,900
+236% +$931K 0.01% 1357
2024
Q1 		$374K Sell
2,500
-7,000
-74% -$1.17M ﹤0.01% 2646
2023
Q4 		$1.82M Buy
+9,500
New +$1.62M 0.01% 1598
2023
Q3 		– Sell
-2,500
Closed -$475K – 4013
2023
Q2 		$475K Buy
+2,500
New +$496K ﹤0.01% 2249
2023
Q1 		– Sell
-100
Closed -$23.8K – 4189
2022
Q4 		$23.8K Sell
100
-100
-50% -$21.3K ﹤0.01% 3983
2022
Q3 		$40K Sell
200
-2,400
-92% -$458K ﹤0.01% 4398
2022
Q2 		$490K Sell
2,600
-1,400
-35% -$199K ﹤0.01% 3853
2022
Q1 		$653K Sell
4,000
-6,200
-61% -$945K ﹤0.01% 2892
2021
Q4 		$1.73M Buy
+10,200
New +$1.9M ﹤0.01% 2038
2021
Q3 		– Sell
-25,000
Closed -$4.24M – 5081
2021
Q2 		$4.24M Buy
25,000
+21,200
+558% +$3.1M 0.01% 1236
2021
Q1 		$537K Buy
+3,800
New +$572K ﹤0.01% 3129
2020
Q4 		– Sell
-22,500
Closed -$3.28M – 4511
2020
Q3 		$3.28M Buy
22,500
+20,300
+923% +$2.88M 0.01% 1254
2020
Q2 		$326K Buy
+2,200
New +$297K ﹤0.01% 3032
2020
Q1 		– Sell
-15,100
Closed -$1.74M – 3935
2019
Q4 		$1.74M Buy
+15,100
New +$1.51M 0.01% 1180
2019
Q2 		– Sell
-22,600
Closed -$2.11M – 3598
2019
Q1 		$2.11M Buy
+22,600
New +$1.89M 0.01% 1263

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Investments's ALNY Position: Q3 2024 in Review

PEAK6 Investments reduced its Alnylam Pharmaceuticals (ALNY) stake by 78% in Q3 2024, selling an estimated $543K and leaving 591 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

PEAK6 Investments first reported a position in ALNY in Q2 2019 and has held it in 19 quarters since. The position peaked at $4.82M in Q2 2020. 567 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • PEAK6 Investments held 591 shares of Alnylam Pharmaceuticals worth $163K as of Q3 2024.
  • PEAK6 Investments sold 2,087 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $543K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2858 holding.
  • PEAK6 Investments first reported a position in Alnylam Pharmaceuticals in Q2 2019 and has held it in 19 quarters since.
  • PEAK6 Investments's Alnylam Pharmaceuticals position peaked at $4.82M in Q2 2020.
  • 567 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.